about
sameAs
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort studyThe Danish Heart RegistryThe Danish Cardiac Rehabilitation DatabaseCause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide studyPharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registriesNon-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case–time–control studyDiabetes is associated with impaired myocardial performance in patients without significant coronary artery disease.The impact of NSAID treatment on cardiovascular risk - insight from Danish observational data.Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data.Identifying Drug-Drug Interactions by Data Mining: A Pilot Study of Warfarin-Associated Drug Interactions.The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study.Accuracy of the ICD-10 discharge diagnosis for syncope.Comparative cardiovascular safety of dementia medications: a cross-national study.Prognosis among healthy individuals discharged with a primary diagnosis of syncope.Evaluation of the CHADS2 risk score on short- and long-term all-cause and cardiovascular mortality after syncope.Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age.Unexplained Syncope and Diagnostic Yield of Tests in Syncope According to the ICD-10 Discharge Diagnosis.Incidence and influence of hospitalization for recurrent syncope and its effect on short- and long-term all-cause and cardiovascular mortality.Syncope and Motor Vehicle Crash Risk: A Danish Nationwide Study.Syncope and Its Impact on Occupational Accidents and Employment: A Danish Nationwide Retrospective Cohort Study.Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort studyTemporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort studyRenal function at the time of a myocardial infarction maintains prognostic value for more than 10 yearsDiabetes is an independent predictor of survival 17 years after myocardial infarction: follow-up of the TRACE registry.Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals.Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort studyDuration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.Body mass index and risk of perioperative cardiovascular adverse events and mortality in 34,744 Danish patients undergoing hip or knee replacement.The prognostic importance of a history of hypertension in patients with symptomatic heart failure is substantially worsened by a short mitral inflow deceleration time.Sarcoidosis in patients with psoriasis: a population-based cohort study.Associations between body mass index and development of metabolic disorders in fertile women--a nationwide cohort study.Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide studyPrognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries.Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort study.Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study.
P50
Q21135505-47516E13-905A-4E4A-A1E4-2551360ACAA0Q28069623-49694802-5035-4F89-B62D-D5C75D7C6582Q28069905-D9D06902-5C80-4275-BA43-E1B493C84CEDQ28485380-47FEE76C-2A52-4E89-844F-226EAE59F8DDQ28730205-5998A51A-C16B-4244-AA89-3B6E380F0513Q28969131-682B6606-EDB2-4616-8231-521E467FD5CEQ30483398-3EE3DE22-9505-4179-A72A-0E397E196A95Q30791071-18A35E7B-FF84-4233-A136-46180CF54427Q30853679-B4544277-E956-40CA-B7F2-D47EB4709C94Q31159433-61EF09ED-D2B4-4034-8D43-1010D98642FAQ31171225-3C5A826E-4A42-493F-BA55-CF9AF9595C22Q33161294-90066E93-4AAA-4766-90DC-A84038372459Q33161992-63E74CF7-EEE9-4FC4-B007-A69BC5551C6BQ33162060-EAFA7AE4-51CF-4E4D-A9F3-03DF357AE7FBQ33162159-EE72D69F-6CF0-48AF-BDAE-A7255B451D86Q33162429-C62BB62E-EE50-47F8-8FB0-16E02AD6E96CQ33163274-6659648F-5A55-4F5F-8BB6-21BA321A505AQ33163463-6E7B11C5-1306-4EB5-A806-C134816D2496Q33164069-67170CEC-5CCB-4E0C-A19E-62C1C19345C7Q33166868-8CE97F4E-D513-4B71-90D9-C20E501CC308Q33168536-C254AB59-F1C9-4AA4-9005-3093784CF86EQ33518180-F4717BD8-365B-4EFF-9137-2D1E358653F5Q33527547-5ADC3F17-084A-4701-A840-B7A9EECEE265Q33794274-4BCFF238-117B-4205-9B83-03FC6F9F3B08Q33943876-F973B81A-5B49-484A-82D2-52CF906E1865Q33945039-92221F6C-26FA-418C-9794-C3E86B909741Q34119616-CB76060A-73BC-4D62-BB7A-9B751A62B46FQ34158078-8F0B450D-82BA-4758-B8ED-2A6BFA29B7D0Q34183822-F1FF2027-5AF1-4933-B67E-067BFDA59028Q34185318-3C8D6BFC-C2BA-4714-8270-1A0313C49766Q34245462-95E26723-4E1A-48FA-8077-35B9BF98FA4AQ34294484-71CB1CE2-70D7-49D5-8F89-D7D9D3F2B52DQ34297146-DF440F83-5362-4C60-B8B2-FECF704FB558Q34343069-9A223777-4571-498E-8785-6C9164ACA17BQ34420240-9D3CB101-9FE7-4B5A-8C10-2D188A47D42FQ34476118-15A49BDE-740C-445F-A3E7-B251445AB4BEQ34532001-3E1C2B43-D672-45E5-9060-E8B3123180DFQ34540479-11BFEAEE-FB2E-4B4E-9438-CF876A280D22Q34540888-4002A754-E2E4-4642-9BD0-F6F2C65FCA91Q34607215-43FDF921-B71F-4CA1-80FF-B8E91156D537
P50
description
hulumtues
@sq
islandzki badacz
@pl
onderzoeker uit IJsland
@nl
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
Gunnar Hilmar Gislason
@ast
Gunnar Hilmar Gislason
@en
Gunnar Hilmar Gislason
@es
Gunnar Hilmar Gislason
@ga
Gunnar Hilmar Gislason
@nl
Gunnar Hilmar Gislason
@sl
type
label
Gunnar Hilmar Gislason
@ast
Gunnar Hilmar Gislason
@en
Gunnar Hilmar Gislason
@es
Gunnar Hilmar Gislason
@ga
Gunnar Hilmar Gislason
@nl
Gunnar Hilmar Gislason
@sl
altLabel
Gunnar H Gislason
@en
Gunnar H. Gislason
@en
prefLabel
Gunnar Hilmar Gislason
@ast
Gunnar Hilmar Gislason
@en
Gunnar Hilmar Gislason
@es
Gunnar Hilmar Gislason
@ga
Gunnar Hilmar Gislason
@nl
Gunnar Hilmar Gislason
@sl
P1053
B-7561-2009
P106
P21
P27
P31
P3829
P496
0000-0002-0548-402X